Early anticoagulation in the current management of NSTE-ACS: Evidence, guidelines, practice and perspectives - International Journal of Cardiology
Strategies for Optimizing Outcomes in the NSTE-ACS Patient: The CATH (Cardiac Catheterization and Antithrombotic Therapy in th
Antithrombotic Management of Elderly Patients With Coronary Artery Disease | JACC: Cardiovascular Interventions
Early anticoagulation in the current management of NSTE-ACS: Evidence, guidelines, practice and perspectives - International Journal of Cardiology
Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy - ScienceDirect
JCM | Free Full-Text | Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology Guidelines | HTML
Antithrombotic treatments in non-ST-segment elevation acute coronary... | Download Scientific Diagram
Management of Antithrombotic Therapy after Acute Coronary Syndromes | NEJM
Open Heart on Twitter: "2020 ESC Guidelines for management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (NSTE-ACS) https://t.co/zacwSn3CaB #ESCCongress @escardio @ESC_Journals @DrPascalMeier @DrMarthaGulati ...
Optimal antiplatelet and anticoagulation strategies in acute coronary syndromes | SpringerLink
2020 ESC Guidelines for the management of acute coronary syndromes - презентация онлайн
Jolanta SillerMatula, MD PhD on Twitter: "NSTE-ACS @escardio guidelines: in patients with #AF: - triple therapy is recommended for 1 week from the acute event, following with a dual therapy using a
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison - ScienceDirect
Optimizing Antithrombotic Strategies in Acute Coronary Syndrome | Frontiers Research Topic
Jolanta SillerMatula, MD PhD on Twitter: "NSTE-ACS @escardio guidelines: - it is not recommended to administer routine pre-treatment with a P2Y12 receptor inhibitor to patients in whom the coronary anatomy is not
Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes
Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: triple versus dual therapy - Journal of Transcatheter Interventions
Antithrombotic strategies in patients with non-ST-elevation acute... | Download Scientific Diagram
Anticoagulant Therapy for Acute Coronary Syndromes | ICR Journal
Optical Coherence Tomography of Plaque Erosion: JACC Focus Seminar Part 2/3 - ScienceDirect
Antithrombotic treatments in non-ST-segment elevation acute coronary... | Download Scientific Diagram
Antithrombotic Management of Atrial Fibrillation Patients Presenting with Coronary Artery Disease: A Consensus Document of the Chinese Society of Cardiology | Cardiology Discovery
![PDF] 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f198f1ecfd9b83165e05420c38d62a3528317347/22-Figure5-1.png "PDF] 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. | Semantic Scholar")
PDF] 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. | Semantic Scholar
Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia study - International Journal of Cardiology
NSTEACS Management Plan - Queensland Health
